Literature DB >> 23567806

Establishing a model for assessing DNA damage in murine brain cells as a molecular marker of chemotherapy-associated cognitive impairment.

Evgeny Krynetskiy1, Natalia Krynetskaia, Diana Rihawi, Katarzyna Wieczerzak, Victoria Ciummo, Ellen Walker.   

Abstract

AIMS: Chemotherapy-associated cognitive impairment often follows cancer chemotherapy. We explored chemotherapy-induced DNA damage in the brain cells of mice treated with 5-fluorouracil (5FU), an antineoplastic agent, to correlate the extent of DNA damage to behavioral functioning in an autoshaping-operant mouse model of chemotherapy-induced learning and memory deficits (Foley et al., 2008). MAIN
METHODS: Male, Swiss-Webster mice were injected once with saline or 75 mg/kg 5FU at 0, 12, and 24h and weighed every 24h. Twenty-four h after the last injection, the mice were tested in a two-day acquisition and the retention of a novel response task for food reinforcement. Murine brain cells were analyzed for the presence of single- and double-strand DNA breaks by the single cell gel electrophoresis assay (the Comet assay). KEY
FINDINGS: We detected significant differences (p<0.0001) for all DNA damage characteristics (DNA "comet" tail shape, migration pattern, tail moment and olive moments) between control mice cohort and 5FU-treated mice cohort: tail length - 119 vs. 153; tail moment - 101 vs. 136; olive moment - 60 vs. 82, correspondingly. We found a positive correlation between increased response rates (r=0.52, p<0.05) and increased rate of errors (r=0.51, p<0.05), and DNA damage on day 1. For all 15 mice (saline-treated and 5FU-treated mice), we found negative correlations between DNA damage and weight (r=-0.75, p<0.02). SIGNIFICANCE: Our results indicate that chemotherapy-induced DNA damage changes the physiological status of the brain cells and may provide insights to the mechanisms for cognitive impairment after cancer chemotherapy.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5-Fluorouracil; Acquisition; Autoshaping; Chemotherapy; Cognition; DNA damage

Mesh:

Substances:

Year:  2013        PMID: 23567806      PMCID: PMC3748161          DOI: 10.1016/j.lfs.2013.03.013

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  25 in total

1.  Effect of the thymidylate synthase inhibitors on dUTP and TTP pool levels and the activities of DNA repair glycosylases on uracil and 5-fluorouracil in DNA.

Authors:  Breeana C Grogan; Jared B Parker; Amy F Guminski; James T Stivers
Journal:  Biochemistry       Date:  2011-01-11       Impact factor: 3.162

2.  A rapid method for the preparation of single-cell suspensions from solid tissues.

Authors:  N P Singh
Journal:  Cytometry       Date:  1998-03-01

3.  A novel model for prediction of human drug clearance by allometric scaling.

Authors:  Huadong Tang; Michael Mayersohn
Journal:  Drug Metab Dispos       Date:  2005-06-15       Impact factor: 3.922

4.  High mobility group protein B1 is an activator of apoptotic response to antimetabolite drugs.

Authors:  Natalia Krynetskaia; Hongbo Xie; Slobodan Vucetic; Zoran Obradovic; Evgeny Krynetskiy
Journal:  Mol Pharmacol       Date:  2007-10-19       Impact factor: 4.436

Review 5.  5-fluorouracil: mechanisms of action and clinical strategies.

Authors:  Daniel B Longley; D Paul Harkin; Patrick G Johnston
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

6.  5-Fluorouracil incorporated into DNA is excised by the Smug1 DNA glycosylase to reduce drug cytotoxicity.

Authors:  Qian An; Peter Robins; Tomas Lindahl; Deborah E Barnes
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

7.  An automated learning and memory model in mice: pharmacological and behavioral evaluation of an autoshaped response.

Authors:  K E Vanover; J E Barrett
Journal:  Behav Pharmacol       Date:  1998-05       Impact factor: 2.293

8.  Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma.

Authors:  G J Peters; J Lankelma; R M Kok; P Noordhuis; C J van Groeningen; C L van der Wilt; S Meyer; H M Pinedo
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

9.  CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

Authors:  Joerg Dietrich; Ruolan Han; Yin Yang; Margot Mayer-Pröschel; Mark Noble
Journal:  J Biol       Date:  2006

10.  Uracil-DNA glycosylases SMUG1 and UNG2 coordinate the initial steps of base excision repair by distinct mechanisms.

Authors:  Henrik Sahlin Pettersen; Ottar Sundheim; Karin Margaretha Gilljam; Geir Slupphaug; Hans Einar Krokan; Bodil Kavli
Journal:  Nucleic Acids Res       Date:  2007-05-30       Impact factor: 16.971

View more
  4 in total

Review 1.  Potential Use of Nicotinic Receptor Agonists for the Treatment of Chemotherapy-Induced Cognitive Deficits.

Authors:  Rex M Philpot
Journal:  Neurochem Res       Date:  2015-02-05       Impact factor: 3.996

2.  Elevated Oxidative Stress and DNA Damage in Cortical Neurons of Chemotherapy Patients.

Authors:  Matthew Torre; Adwitia Dey; Jared K Woods; Mel B Feany
Journal:  J Neuropathol Exp Neurol       Date:  2021-08-11       Impact factor: 3.685

Review 3.  Cognitive Effects of Cancer and Cancer Treatments.

Authors:  Tim A Ahles; James C Root
Journal:  Annu Rev Clin Psychol       Date:  2018-01-18       Impact factor: 22.098

Review 4.  Serotonin, neural markers, and memory.

Authors:  Alfredo Meneses
Journal:  Front Pharmacol       Date:  2015-07-21       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.